Viral Rhinitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2022-08-22
FDA Approved: GUAIFENESIN AND PSEUDOEPHEDRINE HCL — Original Application (Granules India Ltd)
FDA approved Granules India Ltd's guaifenesin and pseudoephedrine HCl as an Original Application (ANDA) for a generic combination product.